Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: GP Combined with Toripalimab Versus GP Induction Chemotherapy for Advanced Childhood Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial comparing GP plus toripalimab versus GP induction chemotherapy in children with advanced nasopharyngeal carcinoma; study statu…
-
CLINICAL_TRIALS research · 2025-03-20Clinical Trial Update: Metastatic Nasopharyngeal Carcinoma [Phase 1]
A Phase 1 clinical trial for metastatic nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 3]
A Phase 3 trial is evaluating toripalimab plus GP induction chemotherapy versus placebo with GP in locoregionally advanced nasopharyngeal ca…
-
CLINICAL_TRIALS research · 2025-03-18Clinical Trial Update: Regulation of Blood-Brain Barrier Permeability by APOE Gene Polymorphism and Its Impact on Cognitive Function Post-Radiotherapy in Nasopharyngeal Carcinoma: An MRI Study
This clinical trial update describes a study investigating how APOE gene polymorphism regulates blood-brain barrier permeability and its imp…
-
CLINICAL_TRIALS research · 2025-03-13Clinical Trial Update: CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma [Phase 3]
Phase 3 trial examines CTV delineation based solely on geometric expansion from GTV in nasopharyngeal carcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-03-11Clinical Trial Update: Comparison and Strategy Optimization of Plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA for Screening Nasopharyngeal Carcinoma in High-risk Areas [NA]
A recruiting clinical trial comparing plasma EBV DNA and P85-Ab with VCA/EBNA1-IgA to screen for nasopharyngeal carcinoma in high-risk areas…
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: A Study of Penpulimab Combination Therapy in Patients With Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 study evaluating penpulimab in combination therapy for advanced nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Concurrent Chemoradiotherapy With Nimotuzumab for High Risk Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial update evaluating nimotuzumab in combination with concurrent chemoradiotherapy for high-risk nasopharyngeal carcinoma…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Sodium Bicarbonate for Reducing Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma. [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating whether sodium bicarbonate can reduce radiation-induced oral mucositis in patients with nasopharyng…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma. [Phase 2]
A Phase 2 clinical trial is evaluating GAPP induction and concurrent chemoradiotherapy followed by toripalimab maintenance for nasopharyngea…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: CD70-targeted immunoPET Imaging of Malignant Cancers [NA]
A clinical trial evaluating CD70-targeted immunoPET imaging in multiple cancers is currently recruiting, including renal cell carcinoma, dif…
-
CLINICAL_TRIALS trial_result · 2025-02-27Clinical Trial Update: A Study of Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial evaluating AK105, an anti-PD-1 therapy, in metastatic nasopharyngeal carcinoma has completed.
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI
This clinical trial entry describes the development and validation of a deep learning model to predict distant metastases in nasopharyngeal …
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Nanatinostat Plus Valganciclovir in Advanced EBV+ Solid Tumors and in Combination With Pembrolizumab in EBV+ RM-NPC [Phase 1]
Phase 1 clinical trial evaluating Nanatinostat with valganciclovir (and in combination with pembrolizumab) for EBV-positive solid tumors, in…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) [Phase 1]
Phase 1 trial evaluating LMP-, BARF1-, and EBNA1-specific cytotoxic T cells for EBV-positive lymphomas; Hodgkin and Non-Hodgkin lymphoma inc…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients [NA]
This clinical trial update reports a study evaluating pretreatment with hydroxychloroquine before radiotherapy and chemotherapy in patients …
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 3]
A Phase III study of YL201 for recurrent or metastatic Nasopharyngeal carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma [Phase 3]
Phase 3 clinical trial evaluating reduced-volume neck prophylactic irradiation in nasopharyngeal carcinoma. The study is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients [Phase 3]
Phase 3 clinical trial evaluating a PD-1 antibody with chemoradiotherapy for recurrent nasopharyngeal carcinoma. The study is currently recr…
-
CLINICAL_TRIALS trial_result · 2025-01-28Clinical Trial Update: Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial assessing a PD-1 antibody in combination with chemoradiotherapy for high-risk recurrent nasopharyngeal carcinoma; the trial is…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma [NA]
A clinical trial is recruiting to evaluate hypofractionated radiotherapy for nasopharyngeal carcinoma at The Second Affiliated Hospital of H…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
A recruiting clinical trial exploring whether circulating tumor cells can detect chemosensitivity and predict treatment efficacy in metastat…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Investigation of Multi-omics Technique to Predict the Efficacy of Chemoradiotherapy Combined With Immunotherapy for r/m NPC
A Sun Yat-sen University trial is evaluating whether a multi-omics approach can predict the efficacy of chemoradiotherapy with immunotherapy…
-
CLINICAL_TRIALS trial_result · 2025-01-27Clinical Trial Update: Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention [NA]
This clinical trial update reports completion of a study evaluating a full-course nutritional intervention delivered via a mobile medical pl…
-
CLINICAL_TRIALS trial_result · 2025-01-23Clinical Trial Update: Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE) [Phase 3]
Phase 3 GEMSTONE study of cadonilimab (PD-1/CTLA-4 bispecific) in combination with chemoradiotherapy for nasopharyngeal carcinoma is current…